Suitability of respiratory endoscopy for sampling malignant thoracic tumors for comprehensive genomic profiling
Cancer Science · 2023
DOI: 10.1111/cas.15951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Kazushi Fujimoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy, Respiratory Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Thoracic Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Comprehensive genomic profiling (CGP) is implemented to detect actionable gene aberrations and design matched therapies. Although malignant thoracic tumors are commonly detected through respiratory endoscopy, it is questionable whether the small specimens obtained thereof are sufficient for CGP. Therefore, this study aimed to investigate the suitability of respiratory endoscopy for sampling primary and metastatic thoracic tumors for CGP. Patients whose specimens were collected through respiratory endoscopy and assessed by pathologists to determine their suitability for CGP at our institution between June 2019 and May 2022 were reviewed retrospectively. The suitability of each procedure as a sampling technique for CGP and, in the cases actually analyzed, the distribution of the detected gene aberration were assessed. In total, 122 patients were eligible for analysis; the median age was 61 (range, 29–86) years, and 71 (58.2%) patients were male. Primary intrathoracic tumors were found in 91 (74.6%) cases, including 84 (68.9%) primary lung cancers; the remaining thoracic metastases of extrathoracic origin included various types. The suitability rates of specimens obtained using conventional bronchoscopy with and without cryobiopsy, endobronchial ultrasound‐guided transbronchial needle aspiration, and medical thoracoscopy were 82.8% (24/29), 70.4% (19/27), 72.9% (35/48), and 100% (18/18), respectively. Of the 96 cases judged suitable, 83 were subjected to CGP, and all but one were successfully analyzed. Finally, 47 (56.6%) patients had at least one actionable gene aberration and eight (9.6%) were treated with the corresponding targeted therapies. In conclusion, specimens obtained through respiratory endoscopy are suitable for CGP; medical thoracoscopy and cryobiopsy in conventional bronchoscopy are particularly useful.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endoscopy, Respiratory Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
- Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
- Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Kazushi Fujimoto
Zitieren
APA
Fujimoto, K., Matsumoto, Y., Imabayashi, T., Uchimura, K., Furuse, H., & Tsuchida, T. (2023). Suitability of respiratory endoscopy for sampling malignant thoracic tumors for comprehensive genomic profiling. Cancer Science. https://doi.org/10.1111/cas.15951
Vancouver
Fujimoto K, Matsumoto Y, Imabayashi T, Uchimura K, Furuse H, Tsuchida T. Suitability of respiratory endoscopy for sampling malignant thoracic tumors for comprehensive genomic profiling. Cancer Science. 2023. doi:10.1111/cas.15951
BibTeX
@article{Fujimoto2023,
author = {Fujimoto, Kazushi and Matsumoto, Yuji and Imabayashi, Tatsuya and Uchimura, Keigo and Furuse, Hideaki and Tsuchida, Takaaki},
title = {Suitability of respiratory endoscopy for sampling malignant thoracic tumors for comprehensive genomic profiling},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15951}
}
EUVIMED